Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats

Abstract Cisplatin (CP) is one of the most frequently used chemotherapy agents. The objective of this design was to determine the ameliorative effect of lycopene (LP) and/or N-acetylcysteine (NAC) in rats with hepatic and renal toxicity induced by CP. Rats were divided randomly into 7 groups (7 rats...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asmaa Elsayed, Ashraf Elkomy, Reda Elkammar, Gehan Youssef, Ehab Yahya Abdelhiee, Walied Abdo, Sabreen Ezzat Fadl, Ahmed Soliman, Mohamed Aboubakr
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/93f4ba69411242e083ca436bf8d26a64
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:93f4ba69411242e083ca436bf8d26a64
record_format dspace
spelling oai:doaj.org-article:93f4ba69411242e083ca436bf8d26a642021-12-02T18:34:20ZSynergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats10.1038/s41598-021-93196-72045-2322https://doaj.org/article/93f4ba69411242e083ca436bf8d26a642021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93196-7https://doaj.org/toc/2045-2322Abstract Cisplatin (CP) is one of the most frequently used chemotherapy agents. The objective of this design was to determine the ameliorative effect of lycopene (LP) and/or N-acetylcysteine (NAC) in rats with hepatic and renal toxicity induced by CP. Rats were divided randomly into 7 groups (7 rats/group): control vehicle group (saline only), the LP group (10 mg/kg, orally), the NAC group (150 mg/kg, orally), the CP group (7.5 mg/kg, IP on day 27), the LP-CP group, the NAC-CP group, and the LP-NAC-CP group. The activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (APK), and levels of urea, creatinine, and lipids (cholesterol, triglycerides, and low-density lipoprotein-cholesterol) increased after CP injection in the serum. Moreover, CP decreased levels of protein, albumin, and HDL cholesterol. Meanwhile, malondialdehyde significantly increased with a decrease in reduced glutathione, superoxide dismutase, and catalase in the liver and kidney tissues. CP also induced some pathological lesions and increased the expression of caspase-3 in the liver and kidney tissues. Administration of LP and NAC alone or in combinations ameliorated hepatorenal toxicity and apoptosis induced by CP.Asmaa ElsayedAshraf ElkomyReda ElkammarGehan YoussefEhab Yahya AbdelhieeWalied AbdoSabreen Ezzat FadlAhmed SolimanMohamed AboubakrNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Asmaa Elsayed
Ashraf Elkomy
Reda Elkammar
Gehan Youssef
Ehab Yahya Abdelhiee
Walied Abdo
Sabreen Ezzat Fadl
Ahmed Soliman
Mohamed Aboubakr
Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats
description Abstract Cisplatin (CP) is one of the most frequently used chemotherapy agents. The objective of this design was to determine the ameliorative effect of lycopene (LP) and/or N-acetylcysteine (NAC) in rats with hepatic and renal toxicity induced by CP. Rats were divided randomly into 7 groups (7 rats/group): control vehicle group (saline only), the LP group (10 mg/kg, orally), the NAC group (150 mg/kg, orally), the CP group (7.5 mg/kg, IP on day 27), the LP-CP group, the NAC-CP group, and the LP-NAC-CP group. The activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (APK), and levels of urea, creatinine, and lipids (cholesterol, triglycerides, and low-density lipoprotein-cholesterol) increased after CP injection in the serum. Moreover, CP decreased levels of protein, albumin, and HDL cholesterol. Meanwhile, malondialdehyde significantly increased with a decrease in reduced glutathione, superoxide dismutase, and catalase in the liver and kidney tissues. CP also induced some pathological lesions and increased the expression of caspase-3 in the liver and kidney tissues. Administration of LP and NAC alone or in combinations ameliorated hepatorenal toxicity and apoptosis induced by CP.
format article
author Asmaa Elsayed
Ashraf Elkomy
Reda Elkammar
Gehan Youssef
Ehab Yahya Abdelhiee
Walied Abdo
Sabreen Ezzat Fadl
Ahmed Soliman
Mohamed Aboubakr
author_facet Asmaa Elsayed
Ashraf Elkomy
Reda Elkammar
Gehan Youssef
Ehab Yahya Abdelhiee
Walied Abdo
Sabreen Ezzat Fadl
Ahmed Soliman
Mohamed Aboubakr
author_sort Asmaa Elsayed
title Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats
title_short Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats
title_full Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats
title_fullStr Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats
title_full_unstemmed Synergistic protective effects of lycopene and N-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats
title_sort synergistic protective effects of lycopene and n-acetylcysteine against cisplatin-induced hepatorenal toxicity in rats
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/93f4ba69411242e083ca436bf8d26a64
work_keys_str_mv AT asmaaelsayed synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT ashrafelkomy synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT redaelkammar synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT gehanyoussef synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT ehabyahyaabdelhiee synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT waliedabdo synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT sabreenezzatfadl synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT ahmedsoliman synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
AT mohamedaboubakr synergisticprotectiveeffectsoflycopeneandnacetylcysteineagainstcisplatininducedhepatorenaltoxicityinrats
_version_ 1718377876367081472